Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.
Li J, Alyamani M, Zhang A, Chang KH, Berk M, Li Z, Zhu Z, Petro M, Magi-Galluzzi C, Taplin ME, Garcia JA, Courtney K, Klein EA, Sharifi N.
Li J, et al. Among authors: petro m.
Elife. 2017 Feb 13;6:e20183. doi: 10.7554/eLife.20183.
Elife. 2017.
PMID: 28191869
Free PMC article.